Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients (vol 9, e15925, 2023)

Heliyon(2023)

引用 0|浏览4
暂无评分
摘要
A novel biomarker of IRPS was constructed to predict the benefit of immunotherapy, which might lead to more individualized prognoses and tailored therapy for kidney cancer patients.
更多
查看译文
关键词
Immune-related genes,Prognostic biomarker,Clear cell renal cell carcinoma,Immunotherapy,TIDE
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要